MedTrace Logo

Effectiveness and Safety of Probiotics in Protecting Liver Function

NCT06607562 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-09-23

No results posted yet for this study

Summary

To evaluate the effectiveness and safety of using probiotics to protect the liver function of long-term alcohol consumers

Conditions

  • Alcohol Abuse

Interventions

DIETARY_SUPPLEMENT

Probiotic group

The experimental phase of this study lasted for 56 days, during which we will measure participants' liver function, such as alanine aminotransferase (ALT) at baseline and end.

DIETARY_SUPPLEMENT

Placebo group

The experimental phase of this study lasted for 56 days, during which we will measure participants' liver function, such as alanine aminotransferase (ALT) at baseline and end.

Sponsors & Collaborators

  • Wecare Probiotics Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Ying Wu, Dr. · Henan University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-03
Primary Completion
2024-12-15
Completion
2025-04-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06607562 on ClinicalTrials.gov